CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-05 | Lurker Nancy Executive Vice Chair | Grant or award · Restricted Stock Units | +38,000 | 38,000 | ||
| 2024-01-05 | Lurker Nancy Executive Vice Chair | Grant or award · Stock Option (Right to Buy) | +77,000 | 77,000 | ||
| 2024-01-05 | Zaderej Karen L. Director | Grant or award · Stock Option (Right to Buy) | +25,014 | 25,014 | ||
| 2024-01-05 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Grant or award · Restricted Stock Units | +21,000 | 21,000 | ||
| 2024-01-05 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | ||
| 2024-01-05 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Restricted Stock Units | +21,000 | 21,000 | ||
| 2024-01-05 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | ||
| 2024-01-05 | Duker Jay S. President and CEO | Grant or award · Restricted Stock Units | +90,000 | 90,000 | ||
| 2024-01-05 | Duker Jay S. President and CEO | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2024-01-05 | Elston George Chief Financial Officer | Grant or award · Restricted Stock Units | +45,000 | 45,000 | ||
| 2024-01-05 | Elston George Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-01-05 | GUYER DAVID R Director | Grant or award · Stock Option (Right to Buy) | +25,014 | 25,014 |
Page 18 of 18 · 352 trades